Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

OW 2026 14 - 17 November 2026

The predicted impact of CagriSema for the primary prevention of cardiovascular disease in the US population with overweight or obesity

Authors :

Morten Bøttcher1; Tina Landsvig Berentzen2; Benjamin D Bray3; Christa Broholm2; Martin Bøg2; Mattia Ficarelli3; Julie Hviid Hahn-Pedersen2; Salman Ramjaun3; Soeren Mattke4

Affiliations
View Details Hide Details
Download the poster (.pptx) Download the poster (.pdf)
Keywords
Cardiovascular Disease
Congress poster
GLP-1 RA
CagriSema
RWE